Cell Culture Industry Development Analysis Contributing Top Vendor Landscape and Economic Growth 2030Posted by rahul nikade on May 4th, 2023 Cell Culture Industry Data Book Covers Cell Culture, Cell Culture Media, 3D Cell Culture, Primary Cell Culture Markets. Grand View Research’s Cell Culture Industry databook is a collection of market sizing & forecasts insights, market dynamics & trends, opportunity assessment, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses studies. Within the purview of the databook, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research. Cell Culture Market Insights The global cell culture market size was valued at USD 21.05 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 11.9% from 2022 to 2030. Media held the largest revenue share of over 50.0% in 2021 due to the high demand for media products for research and development applications. The availability of a variety of serum- and animal-component-free and customized media alternatives has increased the market penetration for media products. Culture systems dominated the market and accounted for over 25.0% share in 2021. The segment is also expected to register the fastest CAGR over the forecast period due to the development of technologically advanced and automated culturing systems. For instance, in March 2022, CELLINK launched its BIO CELLX bio-dispensing platform for the automation of 3D cell-based assays for drug discovery and cancer research. The biopharmaceuticals segment held the largest revenue share of over 25.0% in 2021. Due to the involvement of mammalian cell lines, such as the Chinese hamster ovary, in the manufacturing of biopharmaceuticals and the rising demand for non-conventional drugs, biopharmaceutical applications of cell culture techniques are expected to witness growth. Cell Culture Media Market Insights The global cell culture media market size was valued at USD 4,075 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 12.23% from 2023 to 2030. The serum free media segment held the highest share of 35.9% of the market in 2022. The use of SFM signifies a significant tool, which allows the researchers to perform specific application or grow a specific cell type without using serum. Advantages of using SFM include increased growth and/or productivity, more consistent performance, better control over physiological sensitivity, and to diminish the risk of infection by serum-borne adventitious agents in the culture. The biopharmaceutical production segment dominated the market with a share of 43.11% in 2022. The biopharmaceutical industry’s demand for more reproducible and better-defined media to meet the expanding production levels while reducing the risk of contamination in the downstream processes is significantly increasing the demand for this market. The liquid media segment captured the highest revenue share of 62.6% in 2022. An increasing number of biologics and biosimilars manufacturers, both downstream and upstream, are switching from premixed powders to liquid media owing to the factors such as rapid mycobacterial growth and high rate of isolation. The pharma and biopharma companies segment captured the highest revenue share of 34.2% in 2022. The expansion of the current manufacturing capacities for biopharmaceuticals drives the demand for cell culture products. Access the Global Cell Culture Industry Data Book, 2022 to 2030, compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competition benchmarking, macro-environmental analyses, and regulatory & technological framework studies 3D Cell Culture Market Insights The global 3D cell culture market size was valued at USD 1.5 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 10.7% during the forecast period. Scaffold-based technology accounted for the largest revenue share of over 68.96% in 2020. The use of hydrogels as scaffolds in 3-dimensional cell culture-based research enables the incorporation of sophisticated biochemical and mechanical signs as a mirror of the native extracellular matrix. The cancer segment dominated the market with the largest revenue share of 24.56% in 2020. The use of spheroids as model systems during the development of anticancer therapies drives R&D in this segment. Moreover, the use of 3-dimensional cellular models for the study of cancer biology in preclinical testing and screening is expected to increase revenue generation in this segment. The biotechnology and pharmaceutical industries segment generated the largest revenue share of over 46% in 2020. 3D cell cultures have advantages in terms of optimal oxygen and nutrient gradients, non-uniform exposure of cells within a spheroid to a drug, and realistic cell-to-cell interactions in comparison to 2D cell culture to study drug candidates. These factors make 3D cell cultures better suited for drug discovery and development, thereby driving the demand. Primary Cell Culture Market Insights The global primary cell culture market size was valued at USD 3.4 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.6% from 2021 to 2028. The reagents and supplements segment dominated the market for primary cell culture and accounted for the largest revenue share of 34.0% in 2020. The growth in the segment is owing to its routine application in research and manufacturing involving primary cell culture. Since primary cells are fragile in nature, the reagents and supplements are considered very crucial for their growth. The enzymatic degradation segment dominated the market for primary cell culture and accounted for the largest revenue share of 33.3% in 2020. The large share of the segment is owing to its high preference over other techniques for separation of primary cells due to the advantages such as less damage to cultures, comparatively fast, and high yield of a representative sample. The vaccine production segment dominated the market for primary cell culture and held the largest revenue share of 12.2% in 2020. This growth is owing to the increasing use of primary animal cultures for virus production that is later used for producing several vaccines such as measles, and hepatitis B. In addition, this has also led to cost reduction associated with the use of animal models for vaccine testing. The animal cells segment dominated the market for primary cell culture and accounted for the largest revenue share of 58.6% in 2020. The growing applications of animal origin primary cells for vaccine development are major factors fueling the segment growth. Animal-derived primary cultures have been used for the development of vaccines against rabies, polio, measles, chickenpox, and hepatitis B. Cell Culture Market – Global Industry Segmentation Cell Culture Industry, By Consumables
Cell Culture Industry, By Product
Cell Culture Media Industry, By Product
Cell Culture Media Industry, By Application
Cell Culture Media Industry, By Type
Cell Culture Media Industry, By End user
3D Cell Culture Industry, By Technology
3D Cell Culture Industry, By Application
3D Cell Culture Industry, By End use
Primary Cell Culture Industry, By Product
Primary Cell Culture Industry, By Separation Methods
Primary Cell Culture Industry, By Cell Type
Primary Cell Culture Industry, By Application
Order your copy of the Free Sample of “Cell Culture Industry Data Book - Cell Culture, Cell Culture Media, 3D Cell Culture, Primary Cell Culture Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Cell Culture Industry Data Book Regional Outlook
Cell Culture Industry Data Book Competitive Landscape Competitive rivalry in the cell culture industry is high due to the presence of a large number of both well-established players and small- to mid-sized companies as well as CROs in the market space. Key players operating in the cell culture industry are –
Go through the table of content of Cell Culture Industry Data Book to get a better understanding of the Coverage & Scope of the study About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: sales@grandviewresearch.com Like it? Share it!More by this author |